Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria

Author:

Lohy Das Jesmin1ORCID,Rulisa Stephen2,de Vries Peter J.3,Mens Petra F.4,Kaligirwa Nadine5,Agaba Steven5,Tarning Joel67ORCID,Karlsson Mats O.1,Dorlo Thomas P. C.18ORCID

Affiliation:

1. Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden

2. Department of Clinical Research, University of Kigali, Kigali, Rwanda

3. Tergooi Hospital, Hilversum, the Netherlands

4. Department of Medical Microbiology, Academic Medical Center, Amsterdam, the Netherlands

5. Center for Treatment and Research on AIDS, Malaria and TB (TRAC PLUS), Rwanda Biomedical Center, Kigali, Rwanda

6. Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

7. Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

8. Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital/the Netherlands Cancer Institute, Amsterdam, the Netherlands

Abstract

The artemisinin-based combination therapy artemether-lumefantrine is commonly used in pregnant malaria patients. However, the effect of pregnancy-related changes on exposure is unclear, and pregnancy has been associated with decreased efficacy in previous studies.

Funder

Netherlands Organisation for Scientific Research-Global Health

Netherlands Organisation for Scientific Research

Wellcome Trust

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference64 articles.

1. World Trade Report 2016

2. Treatment of Malaria in Pregnancy

3. The burden of malaria in pregnancy in malaria-endemic areas

4. World Health Organization. 2015. Guidelines for the treatment of malaria. World Health Organization, Geneva, Switzerland.

5. Physiologic and pharmacokinetic changes in pregnancy

Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3